The Korea Herald · All News

Celltrion launches Omlyclo in Brazil, eyes Latin America growth

· By Jeon Ji-woo
Story summary

Celltrion said Tuesday it has officially launched its autoimmune disease treatment Omlyclo in Brazil, the largest pharmaceutical market in Latin America, as part of its push to expand in the region.

Read at The Korea Herald

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.